search
R&D
Trends
- 1Can AI automate AI research and development yet?●Can AI automate AI R&D yet? https://epoch.ai/publications/innovationeval # HackerNews # Tech # AI
Epoch AI has published a new evaluation examining whether artificial intelligence systems can automate AI research and development itself. The publication, shared on tech discussion forums, tests how well current models perform at the kind of novel, innovative work that drives progress in AI research. It is drawing attention as labs increasingly pitch AI agents as tools for accelerating their own research pipelines.
- 2Sea shanty metal collaboration featuring Jonathan Young gains attention▼Si vous avez besoin d'un petit remontant musical : -> Sea Shanty # Metal avec Jonathan Young, Colm R. McGuinness, Caleb
A musical crossover blending traditional sea shanties with heavy metal is being shared as a pick-me-up, featuring artists Jonathan Young, Colm R. McGuinness and Caleb Hyles. The genre-bending covers, known for turning old sailor songs into full rock arrangements, are being passed along as an energising listen for anyone needing a boost during the day.
- 3SandboxAQ Secures $500 Million To Boost US Quantum Chip R&D▼SandboxAQ Develops US Chip R&D With $500 Million In Quantum Funding
SandboxAQ has drawn attention with news that it is supporting United States semiconductor research and development backed by $500 million in quantum-related funding. The announcement highlights growing investment in quantum technologies and the push to strengthen domestic chip capabilities, placing the company among the players shaping the next generation of US semiconductor innovation.
- 4Pharmaceutical innovation framed as health and growth investment▼Pharmaceutical innovation: A strategic investment in health and growth
The International Federation of Pharmaceutical Manufacturers and Associations is promoting pharmaceutical innovation as a strategic investment that delivers both better health and economic growth. The message positions research and development spending by the industry as beneficial to societies and economies, not only to companies. Beyond this framing, no specific announcement, drug, or policy change is attached to the statement.
- 5Spotify launches Spotify Technology to sell internal software tools●Spotify launches Spotify Technology to sell its internal software tools to other companies, says the brand is ‘becoming the R&D operating system’
Spotify has announced the launch of Spotify Technology, a new business arm that will commercialise the internal software tools the company developed for its own operations, selling them to other companies. Spotify says the brand is 'becoming the R&D operating system', positioning the move as a way to turn its in-house engineering capabilities into a revenue stream beyond music streaming.
- 6
Epoch AI has published a new assessment asking whether today's AI systems can genuinely automate AI research and development. The publication examines how well frontier models perform at the kinds of creative and technical work that drive AI progress, a question central to debates about recursive self-improvement and how fast capabilities might accelerate. Readers are debating how close current systems really are to running research autonomously.
- 7Litai Intelligent Pharma raises nearly 50 million yuan seed round●Litai Intelligent Pharma Secures Nearly 50 Million Yuan in Seed Round Financing to Build a Leading AI-Native Peptide Drug R&D Platform
Chinese AI drug discovery startup Litai Intelligent Pharma has closed a seed funding round of nearly 50 million yuan. The company will use the capital to build an AI-native platform for peptide drug research and development, aiming to speed up the design and discovery of peptide-based therapies. The round puts the young firm among a growing group of Chinese startups applying artificial intelligence to pharmaceutical research.
- 8Intel Joins TSMC at Applied Materials' $5B Chip Lab▼Intel Joins TSMC at Applied Materials’ $5B Chip Lab [2026]
Intel is set to work alongside TSMC at Applied Materials' $5 billion chip research facility, according to reports for 2026. The collaboration would place two of the world's largest chipmakers in the same advanced R&D lab, reflecting the growing industry push to develop next-generation semiconductor manufacturing technology and strengthen domestic chip supply chains.
- 9Building a Science-Smart AI Strategy for R&D▼Bridging the Expectation Gap: Building a Science-Smart AI Strategy for R&D
A new commentary argues that research and development organisations need a science-informed AI strategy to close the gap between what AI is expected to deliver and what it can realistically achieve in the lab. It stresses grounding AI adoption in scientific workflows and realistic goals rather than hype, as labs weigh how best to integrate the technology into research.
- 10SPR Sensor Chips Market Set to Grow Through 2035 on Biologics R&D▼SPR Sensor Chips Market To 2035: Biologics R&D Fuels Forward Growth - News and Statistics
A new market report projects sustained growth for surface plasmon resonance (SPR) sensor chips through 2035, driven largely by rising research and development activity in biologics. The chips, used to study molecular interactions in drug discovery, are benefiting from expanding demand for biopharmaceutical development and increasing investment in laboratory analytics across the life sciences industry.
- 11Dynamiapps flagged with D trust score over unpatched flaws●Dynamiapps holds a D trust score: 16 CVEs, max CVSS 10, and 100% unpatched. Five critical flaws and climbing. Patch or r
Security researcher Hugo Valters published a vendor assessment giving Dynamiapps a D trust score, citing 16 known CVEs with a maximum CVSS of 10 and 100% of vulnerabilities unpatched. Five of the flaws are rated critical. His advice to organisations using the software is blunt: patch or replace it.
- 12Itochu invests in Japanese biotech to back drugmakers' R&D●あとでアンナにも伊藤忠のことを話そう 伊藤忠、国内のバイオ企業に出資 製薬会社の研究開発を支援 https://www. nikkei.com/article/DGXZQOUC072 ZX0X01C26A0000000/ # Apple #
Japanese trading house Itochu has taken a stake in a domestic biotech company, a move aimed at supporting the research and development work of pharmaceutical companies. The news, reported by Nikkei, highlights Itochu's push to expand its presence in the health and life sciences sector beyond traditional trading operations.
- 13Lubrizol Expands Southeast Asia Innovation Center Operations●Lubrizol Strengthens Southeast Asia Innovation Center
Specialty chemicals company Lubrizol is strengthening its innovation center in Southeast Asia, according to an industry news report. The move signals the company's intent to deepen its research and development presence in the region, though further details about investment scale, staffing or timing were not provided.
- 14EU to raise defence spending to €163 billion in 2026●The EU will increase defence investment to 163,000 million euros in 2026, with 20,000 million earmarked for R&D
The European Union plans to increase defence investment to 163 billion euros in 2026, of which 20 billion euros will be earmarked for research and development. The commitment signals a continued push to strengthen European military capabilities and the continent's defence industry, with joint funding priorities shifting toward innovation and technological development alongside conventional rearmament.
- 15
Toyota has opened a new battery research and development center in Michigan, strengthening its push into electrified vehicle technology. The facility will focus on developing advanced battery systems as the automaker scales up its electric and hybrid lineup for the North American market. It adds to Toyota's growing investment in US-based battery production and R&D capacity.